Oct 9, 2024, 18:07
EORTC – TMZ treatment in older patients with glioblastoma and a truly unmethylated MGMT promoter
EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“We’re excited to share the latest findings from the EORTC Brain Tumour Group, exploring TMZ treatment in older adults glioblastoma patients with a truly unmethylated MGMT promoter.
TMZ treatment showed no benefit in this specific patient group, challenging current treatment protocols and paving the way for more personalised therapies.”
Read further.
Source: EORTC/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54